Skip Navigation


JAC Advance Access originally published online on November 16, 2008
Journal of Antimicrobial Chemotherapy 2009 63(2):396-399; doi:10.1093/jac/dkn472
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
63/2/396    most recent
dkn472v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Llor, C.
Right arrow Articles by Miravitlles, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Llor, C.
Right arrow Articles by Miravitlles, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance

Carl Llor1,*, Nuria Sierra2, Silvia Hernández2, Ana Moragas2, Marta Hernández3, Carolina Bayona4 and Marc Miravitlles5

1 Primary Care Centre Jaume I, Tarragona, University Rovira i Virgili, Spain 2 Primary Care Centre Jaume I, Tarragona, Spain 3 Hospital Joan XXIII, Tarragona, Spain 4 Primary Care Centre Valls Urbà, Valls, Spain 5 Department of Pneumology, Institut Clínic del Tòrax (IDIBAPS), Hospital Clinic, CIBER de Enfermedades Respiratorias (CIBERES), Spain

Received 27 July 2008; returned 9 September 2008; revised 5 October 2008; accepted 21 October 2008


* Corresponding author. Tel: +34-671085857; Fax: +34-977248459; E-mail: carles.llor{at}urv.cat

Background: To assess the drug compliance observed among patients with lower respiratory tract infection treated with once-daily, twice-daily and thrice-daily antibiotic regimens.

Methods: We performed a prospective study in the primary care setting including patients with suspected bacterial lower respiratory tract infections, not allergic to β-lactam antimicrobials, macrolides or quinolones, treated with several antibiotic regimens. Patient compliance was assessed by electronic monitoring.

Results: A total of 251 patients were enrolled (136 in the thrice-daily group, 70 in the twice-daily group and 45 in the once-daily group). The mean container openings ranged from 94.3 ± 12.6% with once-daily antibiotics to 74.8 ± 17.7% with thrice-daily drugs (P < 0.001). Seventy-five patients in the thrice-daily group took at least 80% of the medications (55.1%), being significantly less than those receiving twice-daily (71.4%) or once-daily (86.7%; P < 0.001) drugs. Only 20.6% of the patients assigned to the thrice-daily regimens opened the container every 8 ± 4 h during at least 80% of the course. Among the patients assigned the same number of doses daily, compliance was better with the shortest antibiotic courses, being worse with schedules of 7 days or more. The percentage of patients who opened the MEMS container the satisfactory number of times a day was lower among the thrice-daily regimens. Moreover, the thrice-daily group more frequently forgot the afternoon dose.

Conclusions: The rate of compliance was very low, mainly when antibiotics were administered thrice daily and in regimens of 7 days or more. New strategies addressed to improve antibiotic drug compliance are, therefore, necessary.

Keywords: electronic monitoring , RTIs , amoxicillin/clavulanate


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
J. W. L. Cals
Comment on: The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance
J. Antimicrob. Chemother., May 1, 2009; 63(5): 1083 - 1084.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. Llor
The higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance--author's response
J. Antimicrob. Chemother., May 1, 2009; 63(5): 1084 - 1085.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.